SCHEMBL9938274

SCHEMBL9938274

CC(C)C(=O)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.38
CA2 P00918 1/20 0.35
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
AKR1C3 P42330 1/20 0.30
AKR1C2 P52895 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
LMNA P02545 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSD17B10 Q99714 1/20 0.30
ROCK2 O75116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668901 0.89 CA12 (0.41) CA2CA12CA9TDP1LMNA
SCHEMBL996026 0.89 CA12 (0.41) CA2CA12CA9TDP1LMNA
Hydrochloric Acid SCHEMBL23199782 0.88 ESR1 (0.35)
SCHEMBL9938547 0.83 KDM4E (0.40) ELANEHTR1DHTR1BL3MBTL1LMNA
SCHEMBL9938614 0.83 MEN1 (0.42) ELANECA2HTR1DHTR1B
SCHEMBL19253296 0.81 NCEH1 (0.30) SMN1; SMN2
SCHEMBL26104675 0.81 MEN1 (0.30) SMN1; SMN2
SCHEMBL15539879 0.81 KDM4E (0.39) CA2CA12CA9TDP1ALDH1A1
SCHEMBL9938270 0.80 ACHE (0.40)
Hydrochloric Acid SCHEMBL23199797 0.80 CA2 (0.34) ELANECA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed